Kobayashi Pharmaceutical Co., Ltd.TSE: 4967

Kobayashi Pharmaceutical: FY2026(January 1, 2026 - December 31, 2026)1Q Financial Statement Summary

· MarketScreener

DISCLAIMER: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

May 8, 2026

Consolidated Financial Results for the Three Months Ended March 31, 2026 (Under Japanese GAAP)

Company name: Kobayashi Pharmaceutical Co., Ltd. Listing: Tokyo Stock Exchange

Securities code: 4967

URL: https://www.kobayashi.co.jp/

Representative: Norikazu Toyoda, President & CEO

Inquiries: Yumi Nakagawa, Executive Officer, General Manager, Financial Department Telephone: +81-6-6222-0142

Scheduled date to commence dividend payments: -

Preparation of supplementary material on financial results: Yes

Holding of financial results briefing: Yes (for institutional investors and analysts)

(Yen amounts are rounded down to millions, unless otherwise noted.)

  1. Consolidated financial results for the three months ended March 31, 2026 (from January 1, 2026 to March 31, 2026)
    1. Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)

      Net sales

      Operating profit

      Ordinary profit

      Profit attributable to owners of parent

      Three months ended

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      March 31, 2026

      33,665

      3.2

      1,350

      (46.7)

      1,671

      (30.4)

      1,036

      (36.2)

      March 31, 2025

      32,607

      (10.6)

      2,535

      (49.6)

      2,401

      (56.0)

      1,624

      66.5

      Note: Comprehensive income For the three months ended March 31, 2026:

      ¥2,357 million

      [-%]

      For the three months ended March 31, 2025:

      ¥(2,052) million

      [-%]

      Basic earnings per share

      Diluted earnings per share

      Three months ended

      Yen

      Yen

      March 31, 2026

      13.95

      -

      March 31, 2025

      21.86

      -

      Note: Diluted earnings per share for the consolidated fiscal year under review is omitted since there were no potential ordinary shares with a dilutive effect.

    2. Consolidated financial position

    Total assets

    Net assets

    Equity-to-asset ratio

    As of

    Millions of yen

    Millions of yen

    %

    March 31, 2026

    254,864

    208,926

    81.7

    December 31, 2025

    275,329

    211,008

    76.3

    Reference: Equity

    As of March 31, 2026: ¥208,101 million

    As of December 31, 2025: ¥210,206 million

  2. Cash dividends

    Annual dividends per share

    First quarter-end

    Second quarter-end

    Third quarter-end

    Fiscal year-end

    Total

    Fiscal year ended December 31, 2025

    Fiscal year ending December 31, 2026

    Yen

    -

    -

    Yen

    44.00

    Yen

    -

    Yen

    60.00

    Yen

    104.00

    Fiscal year ending December 31, 2026 (Forecast)

    45.00

    61.00

    106.00

    Note: Revisions to the forecast of cash dividends most recently announced: None

  3. Forecast of consolidated financial results for the fiscal year ending December 31, 2026 (from January 1, 2026 to December 31, 2026)

(Percentages indicate year-on-year changes.)

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Basic earnings per share

Fiscal year ending December 31, 2026

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

173,000

4.4

12,500

(16.2)

13,000

(23.5)

10,000

173.5

134.52

Note: Revisions to the earnings forecasts most recently announced: None

* Notes
  1. Significant changes in the scope of consolidation during the period: None

  2. Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: None

  3. Changes in accounting policies, changes in accounting estimates, and restatement

    1. Changes in accounting policies due to revisions to accounting standards and other regulations: None

    2. Changes in accounting policies due to other reasons: None

    3. Changes in accounting estimates: None

    4. Restatement: None

  4. Number of issued shares (common shares)

    1. Total number of issued shares at the end of the period (including treasury shares)

      As of March 31, 2026

      78,050,000 shares

      As of December 31, 2025

      78,050,000 shares

    2. Number of treasury shares at the end of the period

      As of March 31, 2026

      3,711,236 shares

      As of December 31, 2025

      3,711,236 shares

    3. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

Three months ended March 31, 2026

74,338,764 shares

Three months ended March 31, 2025

74,338,819 shares

  • Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm:None

  • Proper use of earnings forecasts, and other special matters

The forward-looking statements, including forecasts of financial results, contained in these materials are based on information available to the Company and on certain assumptions deemed to be reasonable. Actual financial results may differ from the results anticipated in the statements due to various factors.

(Method of accessing supplementary material on financial results)

The Company plans to hold a financial results briefing for institutional investors and analysts on Friday, May 8, 2026. The financial results briefing materials to be distributed at this briefing will be posted on the Company's website on the day of the event.

Quarterly consolidated balance sheet

(Millions of yen)

As of December 31, 2025

As of March 31, 2026

Assets

Current assets

Cash and deposits

62,314

56,729

Notes and accounts receivable - trade

52,180

33,438

Securities

8,300

8,300

Merchandise and finished goods

14,710

17,702

Work in process

2,022

2,227

Raw materials and supplies

6,020

6,569

Other

3,316

2,635

Allowance for doubtful accounts

(45)

(20)

Total current assets

148,820

127,581

Non-current assets

Property, plant and equipment

Buildings and structures, net

33,248

33,138

Machinery, equipment and vehicles, net

7,004

7,184

Tools, furniture and fixtures, net

2,591

2,487

Land

6,211

6,603

Leased assets, net

655

700

Construction in progress

17,656

18,223

Total property, plant and equipment

67,367

68,337

Intangible assets

Goodwill

7,711

7,503

Trademark right

6,566

6,305

Software

2,620

2,573

Other

516

528

Total intangible assets

17,414

16,911

Investments and other assets

Investment securities

31,840

31,535

Long-term loans receivable

1,334

1,363

Retirement benefit asset

891

915

Deferred tax assets

5,264

5,919

Investment property, net

2,442

2,435

Other

1,335

1,287

Allowance for doubtful accounts

(1,382)

(1,423)

Total investments and other assets

41,726

42,033

Total non-current assets

126,508

127,282

Total assets

275,329

254,864

(Millions of yen)

As of December 31, 2025

As of March 31, 2026

Liabilities

Current liabilities

Notes and accounts payable - trade

8,458

7,684

Electronically recorded obligations - operating

6,440

2,923

Accounts payable - other

30,916

16,148

Lease liabilities

319

332

Income taxes payable

1,852

1,364

Accrued consumption taxes

1,138

485

Provision for bonuses

3,052

4,417

Provision for product recall-related losses

2,176

1,592

Other

5,783

6,964

Total current liabilities

60,137

41,911

Non-current liabilities

Lease liabilities

359

395

Retirement benefit liability

989

972

Other

2,833

2,657

Total non-current liabilities

4,182

4,025

Total liabilities

64,320

45,937

Net assets

Shareholders' equity

Share capital

3,450

3,450

Capital surplus

522

522

Retained earnings

204,240

200,816

Treasury shares

(24,767)

(24,767)

Total shareholders' equity

183,444

180,021

Accumulated other comprehensive income

Valuation difference on available-for-sale securities

13,085

13,114

Foreign currency translation adjustment

13,012

14,277

Remeasurements of defined benefit plans

663

688

Total accumulated other comprehensive income

26,761

28,080

Share acquisition rights

793

814

Non-controlling interests

9

10

Total net assets

211,008

208,926

Total liabilities and net assets

275,329

254,864

Quarterly consolidated statement of income

(Millions of yen)

Three months ended March 31, 2025

Three months ended March 31, 2026

Net sales

32,607

33,665

Cost of sales

15,924

16,226

Gross profit

16,682

17,438

Selling, general and administrative expenses

14,147

16,087

Operating profit

2,535

1,350

Non-operating income

Interest income

51

137

Dividend income

6

0

Rental income from real estate

76

71

Subsidy income

8

106

Other

100

85

Total non-operating income

244

401

Non-operating expenses

Interest expenses

4

4

Rental costs on real estate

25

20

Foreign exchange losses

272

2

Provision of allowance for doubtful accounts

56

40

Other

18

11

Total non-operating expenses

378

80

Ordinary profit

2,401

1,671

Extraordinary income

Gain on sale of non-current assets

54

0

Gain on sale of investment securities

16

461

Other

8

5

Total extraordinary income

79

466

Extraordinary losses

Loss on disposal of non-current assets

4

19

Losses related to defective products

688

318

Other

45

62

Total extraordinary losses

738

400

Profit before income taxes

1,743

1,737

Income taxes - current

947

1,343

Income taxes - deferred

(826)

(643)

Total income taxes

120

699

Profit

1,623

1,037

Profit (loss) attributable to non-controlling interests

(1)

1

Profit attributable to owners of parent

1,624

1,036

Quarterly consolidated statement of comprehensive income

(Millions of yen)

Three months ended March 31, 2025

Three months ended March 31, 2026

Profit

1,623

1,037

Other comprehensive income

Valuation difference on available-for-sale securities

(428)

29

Foreign currency translation adjustment

(3,258)

1,265

Remeasurements of defined benefit plans, net of tax

11

24

Total other comprehensive income

(3,676)

1,319

Comprehensive income

(2,052)

2,357

Comprehensive income attributable to

Comprehensive income attributable to owners of parent

(2,050)

2,356

Comprehensive income attributable to non-controlling interests

(1)

1

(Notes on segment information, etc.)

  1. The three months of the previous fiscal year (January 1, 2025 to March 31, 2025)

    Information on sales and the amount of profit or loss for each reported segment, as well as revenue breakdown information

    (Millions of yen)

    Reportable segments

    Other (Note) 1

    Total

    Adjustment amount (Note) 2

    Quarterly Consolidated Statements of

    Income (Note)3

    Domestic Business

    International Business

    Total

    Net sales

    Japan

    22,771

    -

    22,771

    127

    22,898

    -

    22,898

    United States

    -

    4,837

    4,837

    -

    4,837

    -

    4,837

    China

    -

    1,992

    1,992

    -

    1,992

    -

    1,992

    Southeast Asia

    -

    2,038

    2,038

    -

    2,038

    -

    2,038

    Other

    -

    839

    839

    -

    839

    -

    839

    Revenue generated from customer contracts

    22,771

    9,708

    32,480

    127

    32,607

    -

    32,607

    Revenues from external customers

    22,771

    9,708

    32,480

    127

    32,607

    -

    32,607

    Transactions with other segments

    766

    382

    1,148

    1,298

    2,447

    (2,447)

    -

    Total

    23,537

    10,091

    33,629

    1,425

    35,054

    (2,447)

    32,607

    Segment Profit

    2,541

    0

    2,541

    36

    2,578

    (42)

    2,535

    Note: 1. The "Other" category is a business segment that is not included in the reporting segments, and includes transportation, manufacturing and sales of synthetic resin containers, real estate management, advertising planning and production, etc.

    1. The adjustment amount of (42) million yen in segment profit is the elimination of inter-segment transactions.

    2. Segment profit is adjusted to operating income in the quarterly consolidated statements of income.

  2. The three months of the current fiscal year (January 1, 2026 to March 31, 2026)

    Information on sales and the amount of profit or loss for each reported segment, as well as revenue breakdown information

    (Millions of yen)

    Reportable segments

    Other (Note) 1

    Total

    Adjustment amount (Note) 2

    Quarterly Consolidated Statements of

    Income (Note)3

    Domestic Business

    International Business

    Total

    Net sales

    Japan

    23,288

    -

    23,288

    173

    23,462

    -

    23,462

    United States

    -

    4,404

    4,404

    -

    4,404

    -

    4,404

    China

    -

    2,662

    2,662

    -

    2,662

    -

    2,662

    Southeast Asia

    -

    2,013

    2,013

    -

    2,013

    -

    2,013

    Other

    -

    1,123

    1,123

    -

    1,123

    -

    1,123

    Revenue generated from customer contracts

    23,288

    10,203

    33,491

    173

    33,665

    -

    33,665

    Revenues from external customers

    23,288

    10,203

    33,491

    173

    33,665

    -

    33,665

    Transactions with other segments

    1,148

    355

    1,504

    1,470

    2,974

    (2,974)

    -

    Total

    24,437

    10,558

    34,996

    1,643

    36,639

    (2,974)

    33,665

    Segment profit (loss)

    1,684

    (338)

    1,346

    95

    1,441

    (91)

    1,350

    Note: 1. The "Other" category is a business segment that is not included in the reporting segments, and includes transportation, manufacturing and sales of synthetic resin containers, real estate management, advertising planning and production, etc.

    1. Segment profit or loss adjustment amount of (91) million yen is the elimination of inter-segment transactions.

    2. Segment profit or loss is adjusted to operating income in the quarterly consolidated statements of income.